Cord blood transforming growth factor
varies with gestation
Authors: Wagner C. L.; Eicher D. J.; Wagner M. T.; Tribble L. G.
Source: Prenatal and Neonatal Medicine, Volume 6, Number 4, 1 August 2001 , pp. 227-233(7)
Publisher: Parthenon Publishing, part of the Taylor & Francis Group
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Abstract:
Objective To test the hypotheses that transforming growth factor
(TGF
) is present in cord blood and that TGF
concentration is associated with gestational age. Methods Umbilical venous cord blood samples (n = 79) were processed immediately after delivery. Each cord serum sample was analyzed for TGF
concentration by radioimmunoassay. Obstetric and neonatal clinical characteristics were also collected. Prematurity was defined as a gestational age of < 37 weeks. The relationship of TGF
concentration with clinical characteristics of the cohort was determined. Results TGF
was present in all cord blood samples tested. The TGF
concentration in the samples varied significantly as a function of gestational age (p = 0.0001). The mean (± SD) cord serum TGF
concentration was 16.4 ± 5.9 pg/ml in infants of < 37 weeks' and 27.0 ± 9.7 pg/ml in infants of
37 weeks' gestation. A lower mean TGF
concentration was associated with low birth weight (p = 0.002), respiratory distress syndrome (p = 0.004) and with infants whose mothers had received betamethasone for fetal lung maturity (p = 0.004) and tocolytic therapy (p = 0.03); however, these differences were no longer significant after controlling for gestational age. Conclusions Cord blood TGF
concentration and gestational age were strongly associated, independently of birth weight and ethnicity: infants of
37 weeks' gestation had significantly higher TGF
concentrations than those of < 37 weeks.
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content

Click here for Page Help